Details for New Drug Application (NDA): 021078
✉ Email this page to a colleague
The generic ingredient in MALARONE PEDIATRIC is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Summary for 021078
Tradename: | MALARONE PEDIATRIC |
Applicant: | Glaxosmithkline |
Ingredient: | atovaquone; proguanil hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 021078
Mechanism of Action | Dihydrofolate Reductase Inhibitors |
Suppliers and Packaging for NDA: 021078
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MALARONE | atovaquone; proguanil hydrochloride | TABLET;ORAL | 021078 | NDA | GlaxoSmithKline LLC | 0173-0675 | 0173-0675-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0173-0675-01) |
MALARONE | atovaquone; proguanil hydrochloride | TABLET;ORAL | 021078 | NDA | GlaxoSmithKline LLC | 0173-0675 | 0173-0675-02 | 24 TABLET, FILM COATED in 1 DOSE PACK (0173-0675-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG;100MG | ||||
Approval Date: | Jul 14, 2000 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 62.5MG;25MG | ||||
Approval Date: | Jul 14, 2000 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021078
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | MALARONE | atovaquone; proguanil hydrochloride | TABLET;ORAL | 021078-001 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | MALARONE | atovaquone; proguanil hydrochloride | TABLET;ORAL | 021078-001 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | MALARONE PEDIATRIC | atovaquone; proguanil hydrochloride | TABLET;ORAL | 021078-002 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | MALARONE PEDIATRIC | atovaquone; proguanil hydrochloride | TABLET;ORAL | 021078-002 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | MALARONE PEDIATRIC | atovaquone; proguanil hydrochloride | TABLET;ORAL | 021078-002 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | MALARONE PEDIATRIC | atovaquone; proguanil hydrochloride | TABLET;ORAL | 021078-002 | Jul 14, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription